Gregory S. Calip, Ph.D. - Publications

Affiliations: 
2014 Epidemiology University of Washington, Seattle, Seattle, WA 
Area:
Epidemiology, Oncology

88/203 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Huang HC, Guadamuz JS, Hoskins KF, Ko NY, Calip GS. Risk of contralateral breast cancer among Asian/Pacific Islander women in the United States. Breast Cancer Research and Treatment. PMID 37897647 DOI: 10.1007/s10549-023-07140-6  0.318
2022 Coleman C, Yan CH, Ko NY, Nabulsi NA, Hoskins KF, Chiu BC, Calip GS. Physical functioning, frailty and risks of locally-advanced breast cancer among older women. Breast (Edinburgh, Scotland). 64: 19-28. PMID 35468476 DOI: 10.1016/j.breast.2022.04.005  0.316
2022 Wang X, Cho-Phan CD, Hoskins KF, Calip GS. Understanding Racial and Ethnic Inequities in Uptake and Outcomes Following Multigene Prognostic Testing in Early Breast Cancer: The Promise of Real-World Data. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 31: 704-706. PMID 35373264 DOI: 10.1158/1055-9965.EPI-22-0066  0.324
2022 Calip GS, Nabulsi NA, Hubbard C, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D, Ko NY, Hoskins KF, Law EH. Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer. Cancer Causes & Control : Ccc. PMID 35226243 DOI: 10.1007/s10552-022-01561-2  0.308
2021 Yan CH, Coleman C, Nabulsi NA, Chiu BC, Ko NY, Hoskins K, Calip GS. Associations between frailty and cancer-specific mortality among older women with breast cancer. Breast Cancer Research and Treatment. PMID 34241741 DOI: 10.1007/s10549-021-06323-3  0.306
2020 Calip GS, Kidd J, Bernhisel R, Cox HC, Saam J, Rauscher GH, Lancaster JM, Hoskins KF. Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling. Breast Cancer Research and Treatment. PMID 32918117 DOI: 10.1007/S10549-020-05922-W  0.399
2020 Mukand NH, Zolekar A, Ko NY, Calip GS. Risks of second primary gynecologic cancers following ovarian cancer treatment in Asian ethnic subgroups in the United States, 2000-2016. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32856609 DOI: 10.1158/1055-9965.Epi-20-0095  0.368
2020 Zhou J, Calip GS, Rowan S, McGregor JC, Perez RI, Evans CT, Gellad WF, Suda KJ. Potentially Inappropriate Medication Combination with Opioids among Older Dental Patients: A Retrospective Review of Insurance Claims Data. Pharmacotherapy. PMID 32767780 DOI: 10.1002/Phar.2452  0.314
2020 Guadamuz JS, Durazo-Arvizu RA, Daviglus ML, Perreira KM, Calip GS, Nutescu EA, Gallo LC, Castaneda SF, Gonzalez F, Qato DM. Immigration Status and Disparities in the Treatment of Cardiovascular Disease Risk Factors in the Hispanic Community Health Study/Study of Latinos (Visit 2, 2014-2017). American Journal of Public Health. e1-e8. PMID 32673107 DOI: 10.2105/Ajph.2020.305745  0.345
2020 Sweiss K, Calip GS, Holden J, Lewkowski P, Mialik I, Johnson J, Galvin JP, Rondelli D, Patel P. Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 1078155220927436. PMID 32493164 DOI: 10.1177/1078155220927436  0.321
2020 Nabulsi NA, Alobaidi A, Talon B, Asfaw AA, Zhou J, Sharp LK, Sweiss K, Patel PR, Ko NY, Chiu BC, Calip GS. Self-reported health and survival in older patients diagnosed with multiple myeloma. Cancer Causes & Control : Ccc. PMID 32356139 DOI: 10.1007/S10552-020-01305-0  0.334
2020 Christian S, Arain S, Patel P, Khan I, Calip GS, Agrawal V, Sweiss K, Griffin S, Cahill K, Konig H, Esen A, Shergill A, Odenike O, Stock W, Quigley JG. A Multi-institutional Comparison of Mitoxantrone, Etoposide, and Cytarabine (MEC) versus High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia. American Journal of Hematology. PMID 32311140 DOI: 10.1002/Ajh.25838  0.301
2020 Guadamuz JS, Durazo-Arvizu RA, Daviglus ML, Calip GS, Nutescu EA, Qato DM. Citizenship Status and the Prevalence, Treatment, and Control of Cardiovascular Disease Risk Factors Among Adults in the United States, 2011-2016. Circulation. Cardiovascular Quality and Outcomes. 13: e006215. PMID 32151148 DOI: 10.1161/Circoutcomes.119.006215  0.302
2020 Kaplan HG, Calip GS, Malmgren JA. Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders. The Oncologist. PMID 32073195 DOI: 10.1634/Theoncologist.2019-0099  0.408
2020 Calip GS, Patel PR, Sweiss K, Wu Z, Zhou J, Asfaw AA, Adimadhyam S, Lee TA, Chiu BC. Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma. International Journal of Cancer. PMID 31997371 DOI: 10.1002/Ijc.32891  0.343
2020 Ko NY, Hong S, Winn RA, Calip GS. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer. Jama Oncology. PMID 31917398 DOI: 10.1001/Jamaoncol.2019.5672  0.419
2020 Zhou J, Asfaw AA, Nabulsi NA, Mukand NA, Lee I, Ko NY, Boudreau DM, Calip GS. HSR20-113: Diabetes Complications and Risks of Breast Cancer Recurrence Among Older Women Journal of the National Comprehensive Cancer Network. 18: HSR20-113. DOI: 10.6004/Jnccn.2019.7475  0.633
2020 Calip GS, Law EH, Hubbard C, Nabulsi NA, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D. Metastatic-free intervals and risk of breast cancer-specific mortality among patients with hormone receptor-positive breast cancer: A population-based analysis from the Surveillance, Epidemiology, and End Results registries. Journal of Clinical Oncology. 38: e13034-e13034. DOI: 10.1200/Jco.2020.38.15_Suppl.E13034  0.466
2020 Calip GS, Hubbard C, Nabulsi NA, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D, Law EH. Real-world patterns of treatment and recurrence by frailty status among older women with HR-positive, HER2-negative early breast cancer. Journal of Clinical Oncology. 38: 535-535. DOI: 10.1200/Jco.2020.38.15_Suppl.535  0.478
2020 Calip GS, Ko NY, Sweiss KI, Patel PR, Chiu BC-. Abstract PR09: Racial disparities in health insurance status of U.S. adults with hematologic malignancies in states with and without Medicaid expansion: Analyses from the National Cancer Database, 2007-2016 Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-Pr09  0.331
2020 Mukand NH, Zolekar AN, Ko NY, Calip GS. Abstract C020: Racial differences in the risks of second primary gynecologic cancers following chemotherapy for malignant ovarian tumors: Asian subgroups in the United States, 2000-2016 Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-C020  0.333
2020 Zolekar A, Nabulsi NA, Asfaw AA, Zhou J, Sweiss K, Patel PR, Chiu BC-, Nutescu EA, Calip GS. Abstract 5748: Declines in health-related quality of life among older patients diagnosed with hematologic malignancies Cancer Research. 80: 5748-5748. DOI: 10.1158/1538-7445.Am2020-5748  0.392
2020 McCormick C, Ko N, Calip G. MC3 DISPARITIES IN HEALTH INSURANCE STATUS AMONG YOUNG ADULT CANCER PATIENTS IN STATES WITH AND WITHOUT MEDICAID EXPANSION: ANALYSES OF THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS REGISTRIES, 2007 - 2016 Value in Health. 23: S7. DOI: 10.1016/J.Jval.2020.04.037  0.351
2020 Sweiss K, Calip G, Johnson J, Galvin JP, Rondelli D, Patel P. Low Hemoglobin and Creatinine Clearance Correlate with Worse Overall Survival, Treatment-Related Mortality, and Regimen-Related Toxicities in Patients Receiving Allogeneic Stem Cell Transplantation with Fludarabine and Melphalan Conditioning Biology of Blood and Marrow Transplantation. 26: S153-S154. DOI: 10.1016/J.Bbmt.2019.12.705  0.33
2019 Guadamuz JS, Ozenberger K, Qato DM, Ko NY, Saffore CD, Adimadhyam S, Cha AS, Moran KM, Sweiss K, Patel PR, Chiu BC, Calip GS. Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults. Medicine. 98: e17960. PMID 31725657 DOI: 10.1097/Md.0000000000017960  0.367
2019 Malmgren JA, Calip GS, Atwood MK, Mayer M, Kaplan HG. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011. Cancer. PMID 31639221 DOI: 10.1002/Cncr.32531  0.405
2019 Sweiss K, Lee J, Mahmud N, Calip GS, Park Y, Mahmud D, Rondelli D, Patel PR. Combined immune score of lymphocyte to monocyte ratio and immunoglobulin levels predicts treatment-free survival of multiple myeloma patients after autologous stem cell transplant. Bone Marrow Transplantation. PMID 31527821 DOI: 10.1038/S41409-019-0681-3  0.331
2019 Sweiss K, Calip GS, Johnson JJ, Rondelli D, Patel PR. Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma. Bone Marrow Transplantation. PMID 31388085 DOI: 10.1038/S41409-019-0628-8  0.324
2019 Lee I, Adimadhyam S, Nutescu EA, Zhou J, Asfaw AA, Sweiss K, Patel PR, Calip GS. Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study. Pharmacotherapy. PMID 31332810 DOI: 10.1002/Phar.2310  0.316
2019 Sweiss K, Calip GS, Wirth S, Rondelli D, Patel P. Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician-pharmacist clinic. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 1078155219851550. PMID 31189419 DOI: 10.1177/1078155219851550  0.309
2019 Calip GS, Yu O, Boudreau DM, Shao H, Oratz R, Richardson SB, Gold HT. Diabetes and differences in detection of incident invasive breast cancer. Cancer Causes & Control : Ccc. PMID 30949885 DOI: 10.1007/S10552-019-01166-2  0.645
2019 Zhou J, Han J, Nutescu EA, Galanter WL, Walton SM, Gordeuk VR, Saraf SL, Calip GS. Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis. British Journal of Haematology. PMID 30714090 DOI: 10.1111/Bjh.15773  0.352
2019 Zhou J, Sweiss K, Patel PR, Nutescu E, Ko N, Chiu BC, Calip GS. Adherence and cumulative bisphosphonate dose in relation to risk of skeletal-related events among older patients with multiple myeloma. Journal of Clinical Oncology. 37: e18250-e18250. DOI: 10.1200/Jco.2019.37.15_Suppl.E18250  0.384
2019 Zhou J, Sweiss K, Patel PR, Nutescu E, Ko N, Chiu BC, Calip GS. Racial differences in intravenous bisphosphonate utilization among older patients with multiple myeloma. Journal of Clinical Oncology. 37: e18165-e18165. DOI: 10.1200/Jco.2019.37.15_Suppl.E18165  0.37
2019 Ko N, Hong S, Winn R, Calip GS. Insurance status and racial disparities in detection of early-stage breast cancer. Journal of Clinical Oncology. 37: e18121-e18121. DOI: 10.1200/Jco.2019.37.15_Suppl.E18121  0.433
2019 Sweiss K, Calip GS, Galvin JP, Rondelli D, Patel P. High Rates of Varicella Zoster Virus Antibody Seroconversion after Administration of the Adjuvanted, Recombinant Varicella Zoster Vaccine in Multiple Myeloma Patients Undergoing Active Treatment Blood. 134: 3081-3081. DOI: 10.1182/Blood-2019-131914  0.3
2019 Sweiss K, Calip GS, Johnson J, Holden J, Lewkowski P, Mialik I, Galvin JP, Rondelli D, Patel P. Low Pre-Treatment Hemoglobin and Creatinine Clearance Correlate with Worse Overall Survival, Treatment-Related Mortality, and Regimen-Related Toxicities in Patients Undergoing a Reduced-Intensity Allogeneic Stem Cell Transplantation with Fludarabine and Melphalan Blood. 134: 1980-1980. DOI: 10.1182/Blood-2019-131886  0.346
2019 Gross AE, Suda KJ, Zhou J, Calip G, Rowan SA, Hershow R, Perez R, Evans CT, McGregor JC. 1895. Serious Antibiotic-Related Adverse Effects Following Unnecessary Dental Prophylaxis in the United States Open Forum Infectious Diseases. 6: S56-S56. DOI: 10.1093/Ofid/Ofz359.122  0.349
2019 Asfaw A, Talon B, Nabulsi N, Alobaidi A, Zhou J, Sweiss K, Patel P, Chiu B, Calip G. PCN175 DEPRESSIVE SYMPTOMS AND RISK OF CANCER-SPECIFIC MORTALITY AMONG OLDER PATIENTS WITH NON-HODGKIN LYMPHOMA: ANALYSES FROM THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER) MEDICARE HEALTH OUTCOMES SURVEY (MHOS) Value in Health. 22: S89. DOI: 10.1016/J.Jval.2019.04.297  0.357
2019 Coleman C, Lee I, Nutescu E, Sweiss K, Patel P, Chiu B, Calip G. PCN161 RISK OF VENOUS THROMBOEMBOLISM ASSOCIATED WITH INITIATION OF CHEMO-IMMUNOTHERAPY AMONG OLDER PATIENTS WITH NON-HODGKIN LYMPHOMA: DIFFERENCES BY RACE AND SUBTYPE Value in Health. 22: S86. DOI: 10.1016/J.Jval.2019.04.285  0.344
2019 Sweiss K, Calip G, Rondelli D, Patel P. Pre-Transplant Hemoglobin and Creatinine Clearance Correlate with Progression Free Survival in Patients with Myeloma Undergoing Autologous Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 25: S409. DOI: 10.1016/J.Bbmt.2018.12.828  0.322
2018 Sweiss K, Calip GS, Oh AL, Rondelli D, Patel PR. Renal dysfunction within 90 days of FluBu4 predicts early and late mortality. Bone Marrow Transplantation. PMID 30604772 DOI: 10.1038/S41409-018-0361-8  0.345
2018 Calip GS, Moran KM, Sweiss KI, Patel PR, Wu Z, Adimadhyam S, Lee TA, Ko NY, Quigley JG, Chiu BC. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma. Cancer. PMID 30548485 DOI: 10.1002/Cncr.31914  0.301
2018 Zhou J, Han J, Nutescu EA, Patel PR, Sweiss K, Calip GS. Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A Six-Year Propensity Score-Matched Cohort Study. Pharmacotherapy. PMID 30485471 DOI: 10.1002/Phar.2197  0.305
2018 Zueger PM, Holmes HM, Qato DM, Pickard AS, Calip GS, Lee TA. Use of Nonpalliative Medications Following Burdensome Health Care Transitions in Hospice Patients: A Matched Cohort Analysis. Medical Care. PMID 30363022 DOI: 10.1097/Mlr.0000000000001008  0.325
2018 Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT. Risk of Amputations Associated with SGLT2 Inhibitors Compared to DPP-4 Inhibitors: A Propensity-Matched Cohort Study. Diabetes, Obesity & Metabolism. PMID 29971914 DOI: 10.1111/Dom.13459  0.303
2018 Zhou J, Han J, Nutescu EA, Gordeuk VR, Saraf SL, Calip GS. Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study. British Journal of Haematology. PMID 29767446 DOI: 10.1111/Bjh.15396  0.347
2018 Calip GS, Patel PR, Adimadhyam S, Xing S, Wu Z, Sweiss K, Schumock GT, Lee TA, Chiu BC. Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions. International Journal of Cancer. PMID 29603214 DOI: 10.1002/Ijc.31407  0.373
2018 Zhou J, Calip GS, Nutescu EA. A Risk Assessment Model for the Identification of Sickle Cell Disease Patients at Risk for Venous Thromboembolism Blood. 132: 3568-3568. DOI: 10.1182/Blood-2018-99-119286  0.369
2018 Zhou J, Han J, Nutescu EA, Galanter W, Walton SM, Gordeuk VR, Saraf SL, Srisuwananukorn A, Calip GS. Type 2 Diabetes Mellitus in Patients with Sickle Cell Disease: A Population-Based Longitudinal Analysis of Three Cohorts Blood. 132: 4817-4817. DOI: 10.1182/Blood-2018-99-119039  0.389
2018 Sweiss K, Calip GS, Wirth S, Rondelli D, Patel P. Collaborative Physician-Pharmacist Managed Multiple Myeloma Clinic Decreases Polypharmacy, Improves Guideline Adherence, and Prevents Treatment Delays Blood. 132: 3542-3542. DOI: 10.1182/Blood-2018-99-117657  0.373
2018 Sweiss K, Calip GS, Johnson J, Jeong H, Rondelli D, Patel P. Pre-Transplant Hemoglobin and Creatinine Clearance Correlate with Treatment Free Survival in Patients with Myeloma Receiving Mel200 and Autologous Stem Cell Transplantation Blood. 132: 4621-4621. DOI: 10.1182/Blood-2018-99-117623  0.334
2018 Lee I, Adimadhyam S, Nutescu EA, Sweiss K, Patel P, Calip GS. Arterial and Venous Thromboembolic Safety of Bevacizumab in Patients with High Grade Gliomas Blood. 132: 2280-2280. DOI: 10.1182/Blood-2018-99-116938  0.409
2018 Calip GS, Zhou J, Sweiss K, Patel P, Asfaw AA, Lee T, Chiu BC, Nutescu EA. Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma Blood. 132: 4693-4693. DOI: 10.1182/Blood-2018-99-116867  0.418
2018 Calip GS, Sweiss K, Adimadhyam S, Asfaw AA, Zhou J, Wu Z, Lee T, Chiu BC, Patel P. Biologic Disease-Modifying Antirheumatic Drugs and Risk of Multiple Myeloma Blood. 132: 1888-1888. DOI: 10.1182/Blood-2018-99-116412  0.379
2018 Malmgren J, Calip G, Atwood M, Kaplan H. Abstract P6-08-11: Regional variation in de novo metastatic breast cancer survival improvement over time using an institutional registry to support SEER analysis: 1990-2010 Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P6-08-11  0.424
2018 Moran KM, Wu Z, Adimadhyam S, Lee TA, Chiu BC, Calip GS. Abstract 4225: Myelodysplastic syndrome and acute myeloid leukemia following use of chemo-immunotherapy and granulocyte colony-stimulating factors among elderly non-Hodgkin lymphoma patients Epidemiology. 78: 4225-4225. DOI: 10.1158/1538-7445.Am2018-4225  0.402
2017 Abhyankar N, Hoskins KF, Abern MR, Calip GS. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis. Bmc Cancer. 17: 659. PMID 28946846 DOI: 10.1186/S12885-017-3640-7  0.395
2017 Calip GS, Adimadhyam S, Xing S, Rincon JC, Lee WJ, Anguiano RH. Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions. Seminars in Arthritis and Rheumatism. PMID 28410817 DOI: 10.1016/J.Semarthrit.2017.03.010  0.302
2017 Wirtz HS, Calip GS, Buist DS, Gralow JR, Barlow WE, Gray S, Boudreau DM. Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors. American Journal of Epidemiology. 1-12. PMID 28338879 DOI: 10.1093/Aje/Kww242  0.764
2017 Calip GS, Xing S, Jun DH, Lee WJ, Hoskins KF, Ko NY. Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer. Journal of Oncology Practice. JOP2016018317. PMID 28287854 DOI: 10.1200/Jop.2016.018317  0.421
2017 Calip GS, Exten KR, Rauscher GH, Brown K, Bernhisel R, Kidd J, Saam J, Lancaster J, Hoskins K. Family history of breast cancer in non-BRCA male breast cancer: A case-control study. Journal of Clinical Oncology. 35: e13032-e13032. DOI: 10.1200/Jco.2017.35.15_Suppl.E13032  0.401
2017 Brown K, Calip GS, Bernhisel R, Evans B, Rosenthal ET, Saam J, Lancaster J, Hoskins K. Multi-gene hereditary cancer testing among men with breast cancer. Journal of Clinical Oncology. 35: 1532-1532. DOI: 10.1200/Jco.2017.35.15_Suppl.1532  0.324
2017 Sweiss K, Oh A, Calip G, Rondelli D, Patel PR. Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era Biology of Blood and Marrow Transplantation. 23: S144. DOI: 10.1182/Blood.V128.22.4631.4631  0.352
2016 Calip GS, Elmore JG, Boudreau DM. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors. Breast Cancer Research and Treatment. PMID 27826756 DOI: 10.1007/S10549-016-4043-1  0.646
2016 Malmgren JA, Calip GS, Pyott SM, Atwood MK, Kaplan HG. Therapy-related myelodysplastic syndrome following primary breast cancer. Leukemia Research. 47: 178-184. PMID 27414978 DOI: 10.1016/J.Leukres.2016.06.005  0.381
2016 Calip GS, Yu O, Elmore JG, Boudreau DM. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study. Cancer Causes & Control : Ccc. PMID 27053250 DOI: 10.1007/S10552-016-0744-3  0.651
2016 Solanki PA, Ko NY, Qato DM, Calip GS. Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991-2011. Springerplus. 5: 82. PMID 26844029 DOI: 10.1186/S40064-016-1726-3  0.372
2016 Calip GS, Adimadhyam S, Patel PR, Sweiss K, Cha AB, Nagy BJ, Moran KM, Smith SM, Chiu BC. Race and Socioeconomic Factors Influencing Treatment Disparities and Comparative Effectiveness in Very Elderly Patients with Diffuse Large B-Cell Lymphoma Blood. 128: 841-841. DOI: 10.1182/Blood.V128.22.841.841  0.405
2016 Adimadhyam S, Sweiss K, Patel PR, Chiu BC, Calip GS. Racial Differences in Long-Term Risk of Venous Thromboembolism Among Older Patients Following Diagnosis and Treatment of Multiple Myeloma Blood. 128: 2071-2071. DOI: 10.1182/Blood.V128.22.2071.2071  0.397
2016 Abhyankar N, Hoskins K, Abern M, Calip G. PD09-08 SHOULD A MAN WITH A HISTORY OF BREAST CANCER BE SCREENED FOR PROSTATE CANCER? Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2903  0.336
2015 Calip GS, Malmgren JA, Lee WJ, Schwartz SM, Kaplan HG. Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer. Breast Cancer Research and Treatment. PMID 26450505 DOI: 10.1007/S10549-015-3590-1  0.458
2015 Calip GS, Law EH, Ko NY. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors. Breast Cancer Research and Treatment. 151: 687-96. PMID 26012645 DOI: 10.1200/Jco.2015.33.15_Suppl.E12592  0.411
2015 Calip GS, Yu O, Hoskins KF, Boudreau DM. Associations between diabetes medication use and risk of second breast cancer events and mortality. Cancer Causes & Control : Ccc. 26: 1065-77. PMID 25956271 DOI: 10.1007/S10552-015-0599-Z  0.64
2015 Kaplan HG, Malmgren JA, Atwood MK, Calip GS. Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007. Cancer. 121: 2553-61. PMID 25872471 DOI: 10.1002/Cncr.29371  0.395
2015 Calip GS, Hubbard RA, Stergachis A, Malone KE, Gralow JR, Boudreau DM. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment. Pharmacoepidemiology and Drug Safety. 24: 75-85. PMID 24923811 DOI: 10.1002/Pds.3660  0.632
2015 Calip GS, Law E, Lee W, Schwartz S, Ko N. Differences in comorbidity at diagnosis and receipt of adjuvant chemotherapy among older women by race and ethnicity. Journal of Clinical Oncology. 33: e17599-e17599. DOI: 10.1200/Jco.2015.33.15_Suppl.E17599  0.405
2015 Chiu BC, Chen J, Yen Y, Calip GS, Chien C, Ahsan H, Shih YT, Cheng K. Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study Blood. 126: 4198-4198. DOI: 10.1182/Blood.V126.23.4198.4198  0.359
2015 Calip GS, Lee W, Lee TA, Schumock GT, Chiu BC. Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma Blood. 126: 2954-2954. DOI: 10.1182/Blood.V126.23.2954.2954  0.324
2015 Calip GS, Lee W, Lee TA, Schumock GT, Chiu BC. Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors Blood. 126: 2653-2653. DOI: 10.1182/Blood.V126.23.2653.2653  0.318
2015 Calip GS, Boudreau DM. Abstract PD4-6: Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemias among breast cancer survivors Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Pd4-6  0.654
2015 Calip G, Malmgren J, Atwood M, Kaplan H. 77 MYELODYSPLASTIC SYNDROME FOLLOWING PRIMARY BREAST CANCER TREATMENT: CASES FROM A COMMUNITY CANCER CENTER, 1990-2014 Leukemia Research. 39: S37-S38. DOI: 10.1016/S0145-2126(15)30078-3  0.38
2015 Calip GS, Law EH, Ko NY. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors Breast Cancer Research and Treatment. 151: 687-696. DOI: 10.1007/s10549-015-3439-7  0.308
2014 Calip GS, Malone KE, Gralow JR, Stergachis A, Hubbard RA, Boudreau DM. Metabolic syndrome and outcomes following early-stage breast cancer. Breast Cancer Research and Treatment. 148: 363-77. PMID 25301086 DOI: 10.1007/S10549-014-3157-6  0.644
2013 Kaplan HG, Malmgren JA, Li CI, Calip GS. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors. Breast Cancer Research and Treatment. 142: 629-36. PMID 24265034 DOI: 10.1007/S10549-013-2773-X  0.369
2013 Calip GS, Boudreau DM, Loggers ET. Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Breast Cancer Research and Treatment. 138: 225-33. PMID 23358904 DOI: 10.1007/S10549-013-2424-2  0.65
2013 Kaplan HG, Malmgren JA, Calip GS, Li C. MDS/AML risk post-breast cancer and association with age: SEER data 2001-2009. Journal of Clinical Oncology. 31: 554-554. DOI: 10.1200/Jco.2013.31.15_Suppl.554  0.411
2012 Schenk JM, Calip GS, Tangen CM, Goodman P, Parsons JK, Thompson IM, Kristal AR. Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. American Journal of Epidemiology. 176: 156-63. PMID 22759721 DOI: 10.1093/Aje/Kwr524  0.355
Low-probability matches (unlikely to be authored by this person)
2018 Zueger PM, Holmes HM, Calip GS, Qato DM, Pickard AS, Lee TA. Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice. Journal of the American Geriatrics Society. PMID 29509282 DOI: 10.1111/Jgs.15328  0.299
2019 Zueger PM, Holmes HM, Calip GS, Qato DM, Pickard AS, Lee TA. Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission. Journal of General Internal Medicine. PMID 31346909 DOI: 10.1007/S11606-019-05152-X  0.299
2013 Calip GS, McDougall JA, Wheldon MC, Li CI, De Roos AJ. Evaluation of seasonality in the diagnosis of acute myeloid leukaemia among adults in the United States, 1992-2008. British Journal of Haematology. 160: 343-50. PMID 23189956 DOI: 10.1111/Bjh.12137  0.293
2019 Patel H, Calip GS, DiDomenico RJ, Schumock GT, Suda KJ, Lee TA. Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin Before and After the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms. Pharmacotherapy. PMID 31867748 DOI: 10.1002/Phar.2355  0.291
2019 Sweiss K, Oh A, Calip GS, Rondelli D, Patel P. Superior Survival in African American Patients Who Underwent Autologous Stem Cell Transplantation for Multiple Myeloma. Clinical Lymphoma, Myeloma & Leukemia. PMID 31231013 DOI: 10.1016/J.Clml.2019.04.019  0.289
2020 Asfaw A, Lee I, Lee T, Sharp L, Wilken L, Joo M, Calip G. PRS40 RISK OF DIARRHEA IN ADULT PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE TAKING ROFLUMILAST Value in Health. 23: S356. DOI: 10.1016/J.Jval.2020.04.1361  0.288
2021 Zhou J, Cueto J, Ko NY, Hoskins KF, Nabulsi NA, Asfaw AA, Hubbard CC, Mitra D, Calip GS, Law EH. Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race. Breast (Edinburgh, Scotland). 59: 367-375. PMID 34419726 DOI: 10.1016/j.breast.2021.08.005  0.288
2020 Guadamuz JS, Durazo-Arvizu RA, DAVIGLUS ML, Calip G, Nutescu E, Qato D. Abstract P471: Citizenship Status and the Prevalence, Treatment, and Control of Cardiovascular Disease Risk Factors Among Immigrants in United States, 2011-2016 Circulation. 141. DOI: 10.1161/Circ.141.Suppl_1.P471  0.287
2022 Calip GS, Cohen A, Rohrer R, Wang X, Wang X, We A, Wu A, Griffith SD, Showalter TN, Miksad R. Telemedicine Use Among Patients With Metastatic Breast Cancer During the COVID-19 Pandemic: Differences by Race, Age and Region. Pharmacoepidemiology and Drug Safety. PMID 36111444 DOI: 10.1002/pds.5541  0.285
2018 Xing S, Kim S, Schumock GT, Touchette DR, Calip GS, Leow AD, Lee TA. Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies. The Primary Care Companion For Cns Disorders. 20. PMID 29873957 DOI: 10.4088/Pcc.17M02220  0.285
2022 Nabulsi NA, Naing KW, Deng H, Cueto J, Asfaw AA, Hubbard CC, Zhou J, Lee I, Mitra D, Calip GS, Law EH. Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey. Journal of Patient Experience. 9: 23743735221113058. PMID 35846244 DOI: 10.1177/23743735221113058  0.283
2022 Huang HC, Smart MH, Zolekar A, Deng H, Hubbard CC, Hoskins KF, Ko NY, Guadamuz JS, Calip GS. Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity. Breast Cancer Research and Treatment. 193: 707-716. PMID 35460499 DOI: 10.1007/s10549-022-06603-6  0.283
2020 Coleman C, Yan C, Ko N, Chiu B, Calip G. PCN181 PHYSICAL FUNCTIONING, FRAILTY AND RISKS OF LOCALLY-ADVANCED BREAST CANCER AMONG OLDER WOMEN Value in Health. 23: S55. DOI: 10.1016/j.jval.2020.04.1661  0.282
2024 Huang HC, Calip GS, Weiss J, Simons Y, Gadi VK, Danciu OC, Rauscher GH, Hoskins KF. Reduction in Breast Cancer Death With Adjuvant Chemotherapy Among US Women According to Race, Ethnicity, and the 21-Gene Recurrence Score. Journal of the National Comprehensive Cancer Network : Jnccn. 22: e237077. PMID 38190799 DOI: 10.6004/jnccn.2023.7077  0.282
2024 Parab AZ, Kong A, Lee TA, Kim K, Nutescu EA, Malecki KC, Hoskins KF, Calip GS. Socioecologic Factors and Racial Differences in Breast Cancer Multigene Prognostic Scores in US Women. Jama Network Open. 7: e244862. PMID 38568689 DOI: 10.1001/jamanetworkopen.2024.4862  0.281
2018 Lee WJ, Lee TA, Calip GS, Suda KJ, Briars L, Schumock GT. Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 24: 883-891. PMID 29562275 DOI: 10.1093/Ibd/Izx080  0.28
2017 Xing S, Calip GS, Leow AD, Kim S, Schumock GT, Touchette DR, Lee TA. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression. Journal of Diabetes and Its Complications. PMID 29544744 DOI: 10.1016/J.Jdiacomp.2017.12.008  0.279
2019 Sweiss K, Vemu B, Calip GS, Galvin JP, Quigley JG, Mahmud N, Rondelli D, Johnson J, Patel P. Development of a Real Time Pharmacokinetic Testing Method to Allow for Targeted Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Transplant Blood. 134: 3310-3310. DOI: 10.1182/Blood-2019-132216  0.277
2015 Tinto H, Sevene E, Dellicour S, Calip GS, d'Alessandro U, Macete E, Nakanabo-Diallo S, Kazienga A, Valea I, Sorgho H, Valá A, Augusto O, Ruperez M, Menendez C, Ouma P, et al. Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique. Reproductive Health. 12: 112. PMID 26637464 DOI: 10.1186/S12978-015-0101-0  0.271
2017 Lee WJ, Lee TA, Suda KJ, Calip GS, Briars L, Schumock GT. Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis. Rheumatology (Oxford, England). PMID 28431162 DOI: 10.1093/Rheumatology/Kex049  0.271
2017 Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Manyando C, Rulisa S, Desai M, Ouma P, Oneko M, Vala A, Rupérez M, Macete E, Menéndez C, Nakanabo-Diallo S, ... ... Calip G, et al. First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies. Plos Medicine. 14: e1002290. PMID 28463996 DOI: 10.1371/Journal.Pmed.1002290  0.271
2023 Hoskins KF, Calip GS, Huang HC, Ibraheem A, Danciu OC, Rauscher GH. Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer. Jama Oncology. PMID 36795405 DOI: 10.1001/jamaoncol.2022.7705  0.27
2022 Whitaker KD, Wang X, Ascha M, Showalter TN, Lewin HG, Calip GS, Goldstein LJ. Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer. Breast Cancer Research and Treatment. PMID 36028783 DOI: 10.1007/s10549-022-06701-5  0.27
2020 Sweiss K, Vemu B, Calip G, Galvin JP, Mahmud N, Rondelli D, Johnson J, Patel PR. A Real Time Pharmacokinetic Testing Method to Allow Individualized Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Transplant Biology of Blood and Marrow Transplantation. 26: S93-S94. DOI: 10.1016/J.Bbmt.2019.12.595  0.267
2011 Shelley D, Anno J, Tseng TY, Calip G, Wedeles J, Lloyd M, Wolff MS. Implementing tobacco use treatment guidelines in public health dental clinics in New York City. Journal of Dental Education. 75: 527-533. DOI: 10.1002/J.0022-0337.2011.75.4.Tb05076.X  0.266
2018 Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. Predicting Acute Exacerbations in Chronic Obstructive Pulmonary Disease. Journal of Managed Care & Specialty Pharmacy. 24: 265-279. PMID 29485951 DOI: 10.18553/Jmcp.2018.24.3.265  0.266
2017 Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β2-Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid. The Annals of Pharmacotherapy. 1060028017719716. PMID 28677404 DOI: 10.1177/1060028017719716  0.265
2021 Hoskins KF, Danciu OC, Ko NY, Calip GS. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women. Jama Oncology. PMID 33475714 DOI: 10.1001/jamaoncol.2020.7320  0.265
2013 Monahan LJ, Calip GS, Novo PM, Sherstinsky M, Casiano M, Mota E, Dourado I. Impact of the Family Health Program on gastroenteritis in children in Bahia, Northeast Brazil: an analysis of primary care-sensitive conditions. Journal of Epidemiology and Global Health. 3: 175-85. PMID 23932060 DOI: 10.1016/J.Jegh.2013.03.002  0.264
2020 Patel PR, Senyuk V, Sweiss K, Calip GS, Pan D, Rodriguez N, Oh A, Mahmud N, Rondelli D. PARP inhibition synergizes with melphalan but does not reverse resistance completely. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32194286 DOI: 10.1016/J.Bbmt.2020.03.008  0.264
2021 Calip GS, Wadé NB, Guadamuz JS, Wang X, Miksad RA, Whitaker KD. Disparities in cardiovascular disease mortality after breast cancer treatment: Methodological considerations using real-world data. Cancer. 128: 647-650. PMID 34873685 DOI: 10.1002/cncr.34045  0.263
2018 Sweiss K, Oh A, Calip G, Rondelli D, Patel P. Similar survival but increased toxicity with a sequential versus concurrent FluBu4 regimen. Bone Marrow Transplantation. PMID 29703968 DOI: 10.1038/S41409-018-0195-4  0.263
2018 Sweiss K, Lee J, Oh A, Calip G, Mahmud N, Rondelli D, Patel PR. Combined Immune Score of Lymphocyte to Monocyte Ratio and Immunoglobulin Levels Predicts Progression-Free Survival of Myeloma Patients after Autologous Transplant Biology of Blood and Marrow Transplantation. 24: S78-S79. DOI: 10.1016/J.Bbmt.2017.12.663  0.261
2019 Sweiss K, Lee J, Calip G, Mahmud D, Mahmud N, Rondelli D, Patel P. A New Prognostic Score Using Lymphocyte to Monocyte Ratio and Immunoglobulin Levels to Predict Progression in Multiple Myeloma Patients Undergoing Autologous Transplant Biology of Blood and Marrow Transplantation. 25: S384-S385. DOI: 10.1182/Blood-2018-99-118965  0.26
2020 Arain S, Christian S, Patel PR, Sweiss K, Parkin B, Calip GS, Quigley JG. Safety and efficacy of gemtuzumab ozogamicin and venetoclax in patients with relapsed or refractory CD33+ acute myeloid leukemia: A phase Ib study. Journal of Clinical Oncology. 38: TPS7566-TPS7566. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps7566  0.26
2021 Hoskins KF, Calip GS. Racial/Ethnic Differences in the 21-Gene Recurrence Score Assay Among Women With Breast Cancer-Reply. Jama Oncology. PMID 34165511 DOI: 10.1001/jamaoncol.2021.1959  0.26
2023 Guadamuz JS, Wang X, Ryals CA, Miksad RA, Snider J, Walters J, Calip GS. Socioeconomic Status and Inequities In Treatment Initiation and Survival Among Patients With Cancer, 2011-2022. Jnci Cancer Spectrum. PMID 37707536 DOI: 10.1093/jncics/pkad058  0.26
2020 Patel PR, Senyuk V, Sweiss K, Calip G, Oh A, Mahmud N, Rondelli D. Overcoming Melphalan Resistance By Targeting Crucial DNA Repair Pathways in Multiple Myeloma Biology of Blood and Marrow Transplantation. 26: S224-S225. DOI: 10.1016/J.Bbmt.2019.12.203  0.259
2020 Asfaw A, Lee I, Lee T, Sharp L, Wilken L, Joo M, Calip G. PRS65 ADHERENCE AND PERSISTENCE TO ROFLUMILAST AMONG ADULT PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Value in Health. 23: S360-S361. DOI: 10.1016/J.Jval.2020.04.1384  0.259
2015 Dellicour S, Desai M, Aol G, Oneko M, Ouma P, Bigogo G, Burton DC, Breiman RF, Hamel MJ, Slutsker L, Feikin D, Kariuki S, Odhiambo F, Pandit J, Laserson KF, ... Calip G, et al. Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya. Malaria Journal. 14: 461. PMID 26581434 DOI: 10.1186/S12936-015-0950-6  0.259
2020 Augusto O, Stergachis A, Dellicour S, Tinto H, Valá A, Ruperez M, Macete E, Nakanabo-Diallo S, Kazienga A, Valéa I, d'Alessandro U, Ter Kuile FO, Calip GS, Ouma P, Desai M, et al. First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age. Malaria Journal. 19: 144. PMID 32268901 DOI: 10.1186/S12936-020-03210-Y  0.257
2018 Adimadhyam S, Schumock GT, Calip GS, Smith Marsh DE, Layden BT, Lee TA. INCREASED RISK OF MYCOTIC INFECTIONS ASSOCIATED WITH SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS: A PRESCRIPTION SEQUENCE SYMMETRY ANALYSIS. British Journal of Clinical Pharmacology. PMID 30294925 DOI: 10.1111/Bcp.13782  0.255
2019 Alobaidi A, Nabulsi NA, Talon B, Asfaw AA, Zhou J, Sharp LK, Sweiss K, Patel PR, Ko NY, Chiu BC, Calip GS. Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 31872292 DOI: 10.1007/S00520-019-05246-6  0.253
2021 Mukand NH, Ko NY, Nabulsi NA, Hubbard CC, Chiu BC, Hoskins KF, Calip GS. The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women. Breast Cancer (Tokyo, Japan). PMID 34797467 DOI: 10.1007/s12282-021-01309-x  0.253
2023 Guadamuz JS, Wang X, Royce TJ, Calip GS. Sociodemographic Inequities in Telemedicine Use Among US Patients Initiating Treatment in Community Cancer Centers During the Ongoing COVID-19 Pandemic, 2020-2022. Jco Oncology Practice. OP2300144. PMID 37748113 DOI: 10.1200/OP.23.00144  0.251
2020 Sweiss K, Vemu B, Hofmeister CC, Wenzler E, Calip GS, Galvin JP, Mahmud N, Rondelli D, Johnson J, Patel P. Development of a Method for Clinical Pharmacokinetic Testing to Allow for Targeted Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Transplant. British Journal of Clinical Pharmacology. PMID 32285957 DOI: 10.1111/Bcp.14308  0.246
2017 Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. Comparative effectiveness of long-acting beta2 -agonist combined with a long-acting muscarinic antagonist or inhaled corticosteroid in chronic obstructive pulmonary disease. Pharmacotherapy. PMID 28226405 DOI: 10.1002/Phar.1913  0.246
2016 Dellicour S, Aol G, Ouma P, Yan N, Bigogo G, Hamel MJ, Burton DC, Oneko M, Breiman RF, Slutsker L, Feikin D, Kariuki S, Odhiambo F, Calip G, Stergachis A, et al. Weekly miscarriage rates in a community-based prospective cohort study in rural western Kenya. Bmj Open. 6: e011088. PMID 27084287 DOI: 10.1136/Bmjopen-2016-011088  0.244
2019 Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT. Sodium-glucose co-transporter 2 inhibitors and the risk of fractures: A propensity score-matched cohort study. Pharmacoepidemiology and Drug Safety. PMID 31646732 DOI: 10.1002/Pds.4900  0.242
2019 Zhou J, Han J, Nutescu EA, Galanter WL, Walton SM, Gordeuk VR, Saraf SL, Calip GS. Type 2 diabetes in adults with sickle cell disease: can we dive deeper? Response to Skinner et al. British Journal of Haematology. PMID 31066029 DOI: 10.1111/Bjh.15949  0.238
2019 Willey C, Calip GS. How Did Research on Medication Safety in Pregnancy Define, Develop and Advance the Field of Pharmacoepidemiology? Clinical Therapeutics. 41: 2464-2466. PMID 31810581 DOI: 10.1016/J.Clinthera.2019.11.004  0.238
2017 Saffore C, Guadamuz J, Ozenberger K, Adimadhyam S, Calip G. Racial Differences In The Prevalence of Cognitive Impairments And Dementia, Utilization of Chemo-Immunotherapy and Mortality In Elderly Diffuse Large B-Cell Lymphoma Patients Value in Health. 20: A520. DOI: 10.1016/J.Jval.2017.08.689  0.236
2020 Zhou J, Nutescu EA, Han J, Calip GS. Clinical trajectories, healthcare resource use, and costs of long-term hematopoietic stem cell transplantation survivors: a latent class analysis. Journal of Cancer Survivorship : Research and Practice. PMID 31897877 DOI: 10.1007/S11764-019-00842-1  0.235
2016 Lee WJ, Briars L, Lee TA, Calip GS, Suda KJ, Schumock GT. Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. PMID 27537053 DOI: 10.1097/Mib.0000000000000880  0.235
2017 Han J, Zhou J, Saraf SL, Gordeuk VR, Calip GS. Characterization of opioid use in sickle cell disease. Pharmacoepidemiology and Drug Safety. PMID 28815799 DOI: 10.1002/Pds.4291  0.235
2020 Lee I, Lee TA, Crawford SY, Kilpatrick RD, Calip GS, Jokinen JD. Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance. Expert Opinion On Drug Safety. PMID 32662668 DOI: 10.1080/14740338.2020.1792883  0.234
2018 Saffore CD, Ko NY, Holmes HM, Patel PR, Sweiss K, Adimadhyam S, Chiu BC, Calip GS. Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia. Journal of Geriatric Oncology. PMID 30270197 DOI: 10.1016/J.Jgo.2018.09.002  0.229
2016 Sweiss K, Oh AL, Calip GS, Rondelli D, Patel PR. Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era Blood. 128: 4631-4631. DOI: 10.1182/blood.v128.22.4631.4631  0.228
2019 Viner M, Zhou J, Allison D, Han J, Molokie RE, Jain S, Gowhari M, Gordeuk VR, Calip G, Saraf SL. The Morbidity and Mortality of End Stage Renal Disease in Sickle Cell Disease. American Journal of Hematology. PMID 30773675 DOI: 10.1002/Ajh.25439  0.227
2017 Sweiss K, Oh A, Calip G, Quigley J, Rondelli D, Patel PR. Acute Kidney Injury before Day 90 Predicts for Poor Overall Survival after FluBu4 Biology of Blood and Marrow Transplantation. 23: S303-S304. DOI: 10.1016/J.Bbmt.2016.12.222  0.227
2018 Sweiss K, Calip GS, Lee J, Mahmud N, Rondelli D, Patel P. A New Prognostic Score Using Lymphocyte to Monocyte Ratio and Immunoglobulin Levels to Predict Progression in Multiple Myeloma Patients Undergoing Autologous Transplant Blood. 132: 3442-3442. DOI: 10.1182/blood-2018-99-118965  0.223
2020 Lee I, Jokinen JD, Crawford SY, Calip GS, Kilpatrick RD, Lee TA. Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance. Therapeutic Innovation & Regulatory Science. PMID 32720297 DOI: 10.1007/S43441-020-00199-Z  0.222
2021 Parikh RB, Takvorian SU, Vader D, Wileyto EP, Clark AS, Lee DJ, Goyal G, Rocque GB, Dotan E, Geynisman DM, Phull P, Spiess PE, Kim RY, Davidoff AJ, Gross CP, ... ... Calip GS, et al. Impact of the COVID-19 Pandemic on Treatment Patterns for Patients with Metastatic Solid Cancer in the United States. Journal of the National Cancer Institute. PMID 34893865 DOI: 10.1093/jnci/djab225  0.218
2016 Lee W, Briars L, Lee T, Calip G, Suda K, Schumock G. Utilization of Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Juvenile Idiopathic Arthritis Value in Health. 19: A227. DOI: 10.1016/J.Jval.2016.03.1174  0.218
2021 Parikh RB, Takvorian SU, Vader D, Wileyto EP, Clark AS, Lee DJ, Goyal G, Rocque GB, Dotan E, Geynisman DM, Phull P, Spiess PE, Kim RY, Davidoff AJ, Gross CP, ... ... Calip GS, et al. Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer. Medrxiv : the Preprint Server For Health Sciences. PMID 34611665 DOI: 10.1101/2021.09.22.21263964  0.218
2016 Lee WJ, Briars L, Lee TA, Calip GS, Suda KJ, Schumock GT. Use of tumor necrosis factor-alpha inhibitors in children and young adults with juvenile idiopathic arthritis or rheumatoid arthritis. Pharmacotherapy. PMID 27779782 DOI: 10.1002/Phar.1856  0.217
2019 Kaplan HG, Malmgren JA, Calip GS. Granulocyte Colony-Stimulating Factors in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia. Jama Oncology. PMID 31070689 DOI: 10.1001/Jamaoncol.2019.0737  0.215
2020 Suda KJ, Zhou J, Rowan SA, McGregor JC, Perez RI, Evans CT, Gellad WF, Calip GS. Overprescribing of Opioids to Adults by Dentists in the U.S., 2011-2015. American Journal of Preventive Medicine. PMID 32033856 DOI: 10.1016/J.Amepre.2019.11.006  0.212
2018 Suda K, Adimadhyam S, Calip G, Rowan S, Gross AE, Perez R, Hershow R, McGregor JC, Evans C. 1630. Antibiotics Prescribed for Infection Prophylaxis Prior to Dental Procedures Are Frequently Unnecessary in the United States Open Forum Infectious Diseases. 5: S42-S42. DOI: 10.1093/Ofid/Ofy209.100  0.211
2020 Calip GS, Zhou J, Sweiss KI, Patel PR, Ith S, Hubbard CC, Ko NY, Chiu BC. Abstract D092: Racial disparities in HIV-associated lymphoma Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-D092  0.208
2021 Zhou J, Sweiss K, Nutescu EA, Han J, Patel PR, Ko NY, Lee TA, Chiu BC, Calip GS. Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. Jco Oncology Practice. OP2000479. PMID 33449809 DOI: 10.1200/OP.20.00479  0.207
2023 Hantel A, Cernik C, Uno H, Walsh TP, Calip GS, DeAngelo DJ, Lathan CS, Abel GA. Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia. Blood Cancer Journal. 13: 192. PMID 38123559 DOI: 10.1038/s41408-023-00964-x  0.205
2023 Holt HK, Peterson CE, MacLaughlan David S, Abdelaziz A, Sawaya GF, Guadamuz JS, Calip GS. Mediation of Racial and Ethnic Inequities in the Diagnosis of Advanced-Stage Cervical Cancer by Insurance Status. Jama Network Open. 6: e232985. PMID 36897588 DOI: 10.1001/jamanetworkopen.2023.2985  0.204
2019 Grossman S, Nathan JP, Ipema HJ, Ness GL, Tierno HE, Gabay MP, Calip GS. Survey of drug information centers in the United States-2018. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 31743390 DOI: 10.1093/Ajhp/Zxz267  0.202
2022 Calip GS, Meropol NJ, Weinberg DS. Colorectal Cancer Incidence Among Adults Younger Than 50 Years-Understanding Findings From Observational Studies of Lower Gastrointestinal Endoscopy. Jama Oncology. PMID 35511156 DOI: 10.1001/jamaoncol.2022.0863  0.197
2017 Han J, Zhou J, Kondragunta V, Zhang X, Molokie RE, Gowhari M, Hassan J, Jain S, Calip GS, Gordeuk VR, Saraf SL. Erythropoiesis-stimulating agents in sickle cell anaemia. British Journal of Haematology. PMID 28748552 DOI: 10.1111/Bjh.14846  0.187
2021 Moran KM, Calip GS, Lee TA, Koronkowski MJ, Lau DT, Schumock GT. Risk of fall-related injury and all-cause hospitalization of select concomitant central nervous system medication prescribing in older adult persistent opioid users: A case-time-control analysis. Pharmacotherapy. PMID 34328644 DOI: 10.1002/phar.2612  0.182
2021 Guadamuz JS, Durazo-Arvizu RA, Daviglus ML, Calip GS, Nutescu EA, Qato DM. Statin nonadherence in Latino and noncitizen neighborhoods in New York City, Los Angeles, and Chicago, 2012-2016. Journal of the American Pharmacists Association : Japha. PMID 33637436 DOI: 10.1016/j.japh.2021.01.032  0.181
2020 Patel H, DiDomenico RJ, Suda KJ, Schumock GT, Calip GS, Lee TA. Risk of cardiac events with azithromycin-A prediction model. Plos One. 15: e0240379. PMID 33057356 DOI: 10.1371/journal.pone.0240379  0.179
2021 Zhou J, Calip GS, Nutescu EA, Han J, Walton SM, Srisuwananukorn A, Galanter WL. Type 2 diabetes mellitus burdens among adults with sickle cell disease: A 12-year single health system-based cohort analysis. Ejhaem. 2: 94-98. PMID 35846078 DOI: 10.1002/jha2.161  0.162
2023 Goyal G, Lau KW, Wang X, Davidoff AJ, Huntington SF, Jamy O, Calip G, Shah H, Stephens DM, Miksad R, Parikh RB, Takvorian S, Neparidze N, Seymour EK. The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021. Jama Network Open. 6: e2316642. PMID 37273206 DOI: 10.1001/jamanetworkopen.2023.16642  0.146
2021 Miksad RA, Calip GS. Early-onset pancreatic cancer research: Making sense of confounding and bias. Cancer. PMID 34228811 DOI: 10.1002/cncr.33663  0.145
2023 Nabulsi NA, Sharp LK, Sweiss KI, Patel PR, Calip GS, Lee TA. Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 10781552231210788. PMID 37942515 DOI: 10.1177/10781552231210788  0.139
2021 Khouja T, Zhou J, Gellad WF, Mitsantisuk K, Hubbard CC, Yan CH, Sharp LK, Calip GS, Evans CT, Suda KJ. Serious opioid-related adverse outcomes associated with opioids prescribed by dentists. Pain. 163: 1571-1580. PMID 35838648 DOI: 10.1097/j.pain.0000000000002545  0.138
2021 Songer C, Calip GS, Srinivasan N, Barbosa VM, Pham JT. Factors Influencing Antibiotic Duration in Culture-Negative Neonatal Early-Onset Sepsis. Pharmacotherapy. PMID 33527426 DOI: 10.1002/phar.2507  0.136
2023 Zhao Y, Howard R, Amorrortu RP, Stewart SC, Wang X, Calip GS, Rollison DE. Assessing the Contribution of Scanned Outside Documents to the Completeness of Real-World Data Abstraction. Jco Clinical Cancer Informatics. 7: e2200118. PMID 36791386 DOI: 10.1200/CCI.22.00118  0.135
2023 Canavan M, Wang X, Ascha M, Miksad R, Showalter TN, Calip G, Gross CP, Adelson K. End-of-Life Systemic Oncologic Treatment in the Immunotherapy Era: The Role of Race, Insurance, and Practice Setting. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2202180. PMID 37339389 DOI: 10.1200/JCO.22.02180  0.127
2022 Kumar S, Wang X, Pittell H, Calip GS, Weiss SE, Meyer JE, Royce TJ. Real world use of radiation for newly diagnosed brain metastases in ALK-positive lung cancer receiving a first line ALK inhibitor. International Journal of Radiation Oncology, Biology, Physics. PMID 35870711 DOI: 10.1016/j.ijrobp.2022.07.010  0.124
2018 Sweiss K, Oh A, Calip G, Quigley J, Rondelli D, Patel PR. Similar Survival but Increased Toxicity with a Sequential Versus Concurrent FluBu4 Regimen Biology of Blood and Marrow Transplantation. 24: S305-S306. DOI: 10.1016/j.bbmt.2017.12.351  0.122
2020 Pham JT, Jacobson JL, Ohler KH, Kraus DM, Calip GS. Evaluation of the Risk Factors for Acute Kidney Injury in Neonates Exposed to Antenatal Indomethacin. The Journal of Pediatric Pharmacology and Therapeutics : Jppt : the Official Journal of Ppag. 25: 606-616. PMID 33041715 DOI: 10.5863/1551-6776-25.7.606  0.121
2024 Pittell H, Calip GS, Pierre A, Ryals CA, Guadamuz JS. Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer. Breast Cancer Research and Treatment. PMID 38702585 DOI: 10.1007/s10549-024-07319-5  0.12
2023 Ramanathan S, Yan CH, Hubbard C, Calip GS, Sharp LK, Evans CT, Rowan S, McGregor JC, Gross AE, Hershow RC, Suda KJ. Changes in antibiotic prescribing by dentists in the United States, 2012-2019. Infection Control and Hospital Epidemiology. 1-6. PMID 37605940 DOI: 10.1017/ice.2023.151  0.115
2021 Talon B, Calip GS, Lee TA, Sharp LK, Patel P, Touchette DR. Trend in Tyrosine Kinase Inhibitor Utilization, Price, and Out-of-Pocket Costs in Patients With Chronic Myelogenous Leukemia. Jco Oncology Practice. OP2000967. PMID 33961496 DOI: 10.1200/OP.20.00967  0.109
2021 Zhou J, Sweiss K, Han J, Ko NY, Patel PR, Chiu BC, Calip GS. Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma. Jama Network Open. 4: e2118410. PMID 34313746 DOI: 10.1001/jamanetworkopen.2021.18410  0.108
2024 Ramanathan S, Evans CT, Hershow RC, Calip GS, Rowan S, Hubbard C, Suda KJ. Guideline concordance and antibiotic-associated adverse events between Veterans administration and non-Veterans administration dental settings: a retrospective cohort study. Frontiers in Pharmacology. 15: 1249531. PMID 38292941 DOI: 10.3389/fphar.2024.1249531  0.106
2023 Vader DT, Mamtani R, Li Y, Griffith SD, Calip GS, Hubbard RA. Inverse Probability of Treatment Weighting and Confounder Missingness in Electronic Health Record-based Analyses: A Comparison of Approaches Using Plasmode Simulation. Epidemiology (Cambridge, Mass.). PMID 37155612 DOI: 10.1097/EDE.0000000000001618  0.101
2022 Mohyuddin GR, Chakraborty R, Calip GS, Ascha MS, Wang X, Rubinstein SM, Tuchman S, Costa L, Haaland B, Giri S, Mian H, Fonseca R, Sborov D. Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood Cancer Journal. 12: 168. PMID 36526617 DOI: 10.1038/s41408-022-00769-4  0.094
2019 Saffore C, Chiu B, Calip G. PCN157 ASSOCIATION BETWEEN CHEMO-IMMUNOTHERAPY AND DEVELOPMENT OF MILD COGNITIVE IMPAIRMENT OR DEMENTIA IN OLDER PATIENTS WITH NON-HODGKIN LYMPHOMA Value in Health. 22: S85-S86. DOI: 10.1016/J.JVAL.2019.04.281  0.09
2023 Pittell H, Calip GS, Pierre A, Ryals CA, Altomare I, Royce TJ, Guadamuz JS. Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022. Jama Network Open. 6: e2322515. PMID 37477920 DOI: 10.1001/jamanetworkopen.2023.22515  0.085
2020 Gross AE, Suda KJ, Zhou J, Calip GS, Rowan SA, Hershow RC, Perez R, Evans CT, McGregor JC. Serious antibiotic-related adverse effects following unnecessary dental prophylaxis in the United States. Infection Control and Hospital Epidemiology. 1-3. PMID 33172505 DOI: 10.1017/ice.2020.1261  0.081
2022 Hubbard CC, Evans CT, Calip GS, Zhou J, Rowan SA, Suda KJ. Appropriateness of Antibiotic Prophylaxis Before Dental Procedures, 2016-2018. American Journal of Preventive Medicine. PMID 35012829 DOI: 10.1016/j.amepre.2021.11.004  0.08
2023 Ramanathan S, Evans CT, Hershow RC, Calip GS, Rowan S, Hubbard C, Suda KJ. Comparison of guideline concordant antibiotic prophylaxis in Veterans Affairs and non-Veterans Affairs dental settings among those with cardiac conditions or prosthetic joints. Bmc Infectious Diseases. 23: 427. PMID 37353757 DOI: 10.1186/s12879-023-08400-y  0.078
2021 Hubbard CC, Evans CT, Calip GS, Rowan SA, Gellad WF, Campbell A, Gross AE, Hershow RC, McGregor JC, Sharp LK, Suda KJ. Characteristics Associated With Opioid and Antibiotic Prescribing by Dentists. American Journal of Preventive Medicine. PMID 33745816 DOI: 10.1016/j.amepre.2020.11.017  0.076
2019 Suda KJ, Durkin MJ, Calip GS, Gellad WF, Kim H, Lockhart PB, Rowan SA, Thornhill MH. Comparison of Opioid Prescribing by Dentists in the United States and England. Jama Network Open. 2: e194303. PMID 31125102 DOI: 10.1001/jamanetworkopen.2019.4303  0.073
2021 Calip GS, Yerram P, Ascha MS. Nonrandomized Comparison of Adverse Events Following Facility- and Home-Infused Biologics Using Real-World Data. Jama Network Open. 4: e2111156. PMID 34081142 DOI: 10.1001/jamanetworkopen.2021.11156  0.071
2020 Patel H, Calip GS, DiDomenico RJ, Schumock GT, Suda KJ, Lee TA. Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin. Jama Network Open. 3: e2016864. PMID 32930780 DOI: 10.1001/jamanetworkopen.2020.16864  0.071
2019 Suda KJ, Calip GS, Zhou J, Rowan S, Gross AE, Hershow RC, Perez RI, McGregor JC, Evans CT. Assessment of the Appropriateness of Antibiotic Prescriptions for Infection Prophylaxis Before Dental Procedures, 2011 to 2015. Jama Network Open. 2: e193909. PMID 31150071 DOI: 10.1001/jamanetworkopen.2019.3909  0.067
2022 Kim KC, Khouja T, Burgette JM, Evans CT, Calip GS, Gellad WF, Suda KJ. Trends in Dispensed Prescriptions for Opioids, Sedatives, Benzodiazepines, Gabapentin, and Stimulants to Children by General Dentists, 2012-2019. Pharmacoepidemiology and Drug Safety. PMID 36573575 DOI: 10.1002/pds.5589  0.057
2022 Yan CH, Ramanathan S, Suda KJ, Khouja T, Rowan SA, Evans CT, Lee TA, Calip GS, Gellad WF, Sharp LK. Barriers to and facilitators of opioid prescribing by dentists in the United States: A qualitative study. Journal of the American Dental Association (1939). PMID 35863973 DOI: 10.1016/j.adaj.2022.05.009  0.054
2022 Yan CH, Lee TA, Sharp LK, Hubbard CC, Evans CT, Calip GS, Rowan SA, McGregor JC, Gellad WF, Suda KJ. Trends in Opioid Prescribing by General Dentists and Dental Specialists in the U.S., 2012-2019. American Journal of Preventive Medicine. PMID 35232618 DOI: 10.1016/j.amepre.2022.01.009  0.052
2023 Calip GS, Royce TJ. External validity of lymphoma clinical trials. Blood. 142: 757-759. PMID 37651155 DOI: 10.1182/blood.2023021222  0.049
2022 Canavan ME, Wang X, Ascha MS, Miksad RA, Calip GS, Gross CP, Adelson KB. Systemic Anticancer Therapy at the End of Life-Changes in Usage Pattern in the Immunotherapy Era. Jama Oncology. PMID 36264566 DOI: 10.1001/jamaoncol.2022.4666  0.046
2023 Calip GS, Altomare IP, Guadamuz JS. Evaluating External Validity of Oncology Biosimilar Safety Studies. Jama Network Open. 6: e235776. PMID 37022693 DOI: 10.1001/jamanetworkopen.2023.5776  0.037
2021 Calip GS, Miksad RA, Sarkar S. Time-Related Biases in Nonrandomized COVID-19-Era Studies Using Real-world Data. Jama Oncology. PMID 34137793 DOI: 10.1001/jamaoncol.2021.1715  0.032
2019 Lee I, Sharma D, Duhig J, Jokinen J, Calip G, Lievano F, Scarazzini L. PNS136 INTERVENTIONS OR CURRENT PRACTICES WITHIN PHARMACIES TO PREVENT DISPENSING ERRORS IN DEVELOPED COUNTRIES: A SYSTEMATIC REVIEW Value in Health. 22: S308. DOI: 10.1016/J.JVAL.2019.04.1493  0.019
Hide low-probability matches.